6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID

Star0

DB08467ExperimentalSmall molecule

6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID: Overview.

Formula / weight: C₂₀H₂₈O₂ · 300.4351 g/mol (avg)

Resolves to

Compound

PubChem5289278

Structure

InChIKeyHEVXQLBAMFMFKU-IAZPEVBMSA-NSMILESO=C(O)\C=C(/C)\C=C\C[C@]1(C)CC2=C(CCCC2(C)C)C1=C

What you can answer from here — as of April 02, 2025

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of 6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account